School of Humanities and Sciences
Showing 101-120 of 2,090 Results
-
Rodrigo Bello Carvalho
Ph.D. Student in Biology, admitted Autumn 2023
BioI am a field biologist deeply passionate about wildlife ecology and conservation. Holding a Master's degree in Biodiversity Conservation and Management from the University of Oxford (2021), I graduated with honors in Biological Sciences - B.Sc. (2017) and B.Ed. (2018) - from the University of Brasília (UnB).
My passion for wildlife ecology began during my time at the UnB Ecosystem Ecology Lab (2014-2018) under Prof. Mercedes Bustamante, focusing on Cerrado ecosystem ecology. Following this, I worked at the Brasília Zoological Garden Foundation (2018) before teaching Science and Biology in Brasília (2019).
At Oxford's Ecosystems Lab (2020-2021), I researched seed dispersal and defaunation in the Cerrado with Dr. Imma Oliveras and Prof. Yadvinder Malhi for my Master's dissertation. My commitment to conservation led me to the 'Chico Mendes Institute for Biodiversity Conservation' (ICMBio) (2022-2023), where I served as an Environmental Analyst in the Western Brazilian Amazon.
Currently, I am a Biology PhD student in the Dirzo lab at Stanford University, where I investigate animal-ecosystem/ plant-frugivore interactions between Brazilian and African savannahs. I also collaborate at UNESP's Bird Ecology Lab, exploring frugivory and seed dispersal in the Atlantic Forest.
My academic pursuits are deeply rooted in the ecology and conservation of large-bodied vertebrates and plant communities within tropical ecosystems. I am particularly fascinated by their intricate ecological interactions, such as frugivory, seed dispersal, and herbivory, as well as the pressing challenges posed by defaunation and deforestation. -
Stacey Bent
Vice Provost, Graduate Edu & Postdoc Affairs, Jagdeep & Roshni Singh Professor in the School of Engineering, Professor of Energy Science Eng, Sr Fellow at Precourt & Professor, by courtesy, of Electrical Eng, Materials Sci Eng & Chemistry
BioThe research in the Bent laboratory is focused on understanding and controlling surface and interfacial chemistry and applying this knowledge to a range of problems in semiconductor processing, micro- and nano-electronics, nanotechnology, and sustainable and renewable energy. Much of the research aims to develop a molecular-level understanding in these systems, and hence the group uses of a variety of molecular probes. Systems currently under study in the group include functionalization of semiconductor surfaces, mechanisms and control of atomic layer deposition, molecular layer deposition, nanoscale materials for light absorption, interface engineering in photovoltaics, catalyst and electrocatalyst deposition.
-
Dominique Bergmann
Shirley R. and Leonard W. Ely, Jr. Professor of the School of Humanities and Sciences
Current Research and Scholarly InterestsWe use genetic, genomic and cell biological approaches to study cell fate acquisition, focusing on cases where cell fate is correlated with asymmetric cell division.
-
Louis Berrios
Postdoctoral Scholar, Biology
BioLouis joined the Peay lab in 2021 after completing his Ph.D. at the University of South Carolina. His research primarily focuses on the factors that govern the spatial distributions of bacteria and fungi as a function of microbe-microbe and plant-microbe interactions. From genomes to phenomes, Louis fuses both top-down and bottom-up experimental approaches to determine the genetic architecture that undergirds plant microbiome assemblages across landscapes.
-
Carolyn Bertozzi
Baker Family Director of Sarafan ChEM-H, Anne T. and Robert M. Bass Professor in the School of Humanities and Sciences and Professor, by courtesy, of Chemical and Systems Biology and of Radiology
BioProfessor Carolyn Bertozzi's research interests span the disciplines of chemistry and biology with an emphasis on studies of cell surface sugars important to human health and disease. Her research group profiles changes in cell surface glycosylation associated with cancer, inflammation and bacterial infection, and uses this information to develop new diagnostic and therapeutic approaches, most recently in the area of immuno-oncology.
Dr. Bertozzi completed her undergraduate degree in Chemistry at Harvard University and her Ph.D. at UC Berkeley, focusing on the chemical synthesis of oligosaccharide analogs. During postdoctoral work at UC San Francisco, she studied the activity of endothelial oligosaccharides in promoting cell adhesion at sites of inflammation. She joined the UC Berkeley faculty in 1996. A Howard Hughes Medical Institute Investigator since 2000, she came to Stanford University in June 2015, among the first faculty to join the interdisciplinary institute ChEM-H (Chemistry, Engineering & Medicine for Human Health). She is now the Baker Family Director of Stanford ChEM-H.
Named a MacArthur Fellow in 1999, Dr. Bertozzi has received many awards for her dedication to chemistry, and to training a new generation of scientists fluent in both chemistry and biology. She has been elected to the Institute of Medicine, National Academy of Sciences, and American Academy of Arts and Sciences; and received the Lemelson-MIT Prize, the Heinrich Wieland Prize, the ACS Award in Pure Chemistry, and the Chemistry of the Future Solvay Prize, among others.
The Bertozzi Group develops chemical tools to study the glycobiology underlying diseases such as cancer, inflammation, tuberculosis and most recently COVID-19. She is the inventor of "bioorthogonal chemistry", a class of chemical reactions compatible with living systems that enable molecular imaging and drug targeting. Her group also developed new therapeutic modalities for targeted degradation of extracellular biomolecules, such as antibody-enzyme conjugates and Lysosome Targeting Chimeras (LYTACs). As well, her group studies NGly1 deficiency, a rare genetic disease characterized by loss of the human N-glycanase.
Several of the technologies developed in the Bertozzi lab have been adapted for commercial use. Actively engaged with several biotechnology start-ups, Dr. Bertozzi cofounded Redwood Bioscience, Enable Biosciences, Palleon Pharmaceuticals, InterVenn Bio, OliLux Bio, Grace Science LLC and Lycia Therapeutics. She is also a member of the Board of Directors of Lilly.
